SCHEMBL3348501

SCHEMBL3348501

O=C(c1ccccc1)c1ccc(C[C@H](O)C(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
KDM6B O15054 1/20 0.51
SRD5A2 P31213 4/20 0.50
PPARG P37231 2/20 0.50
PPARD Q03181 1/20 0.50
PPARA Q07869 1/20 0.50
MAPK13 O15264 1/20 0.48
MAPK12 P53778 1/20 0.48
MAPK11 Q15759 1/20 0.48
MAPK14 Q16539 1/20 0.48
MDM2 Q00987 1/20 0.47
CYP1A2 P05177 1/20 0.47
PTPRA P18433 1/20 0.46
ATM Q13315 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2033689 1.00 ALDH1A1 (0.52) ALDH1A1KDM6BSRD5A2PPARGPPARD
SCHEMBL15391739 0.85 MDM2 (0.60) ALDH1A1SRD5A2PPARGPPARDPPARA
SCHEMBL57558 0.84 CYP1A2 (0.64) KDM6BMDM2CYP1A2PTPRAALPI
SCHEMBL8953468 0.84 CYP1A2 (0.64) KDM6BMDM2CYP1A2PTPRAALPI
SCHEMBL180366 0.84 CYP1A2 (0.64) KDM6BMDM2CYP1A2PTPRAALPI
SCHEMBL197252 0.84 CYP1A2 (0.64) KDM6BMDM2CYP1A2PTPRAALPI
SCHEMBL10891346 0.84 KDM6B (0.67) KDM6BCYP1A2PTPRALMNAALPI
SCHEMBL11882593 0.83 CYP1A2 (0.70) ALDH1A1SRD5A2PPARGPPARDPPARA
SCHEMBL6243190 0.82 KDM6B (0.56) ALDH1A1KDM6BSRD5A2L3MBTL1TDP1
SCHEMBL11827641 0.82 ALDH1A1 (0.48) ALDH1A1SRD5A2PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190330618-A1 ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES NUEVOLUTION AS (DK) 2019-10-31 US disclosed
US-8883720-B2 Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity POLYPHOR AG (CH) 2014-11-11 US disclosed
US-20110312879-A1 TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS WITH CXCR4 ANTAGONIZING ACTIVITY POLYPHOR AG (CH) 2011-12-22 US disclosed
WO-2010060479-A1 TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS WITH CXCR4 ANTAGONIZING ACTIVITY POLYPHOR AG (CH) 2010-06-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312879-A1 TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS WITH CXCR4 ANTAGONIZING ACTIVITY CXCL12, CXCR4, CXCR1 ALDH1A1 2448/4885KDM6B 4503/4885SRD5A2 4249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.